We describe procedures to quantify and characterize atherosclerotic lesions in mouse models using precision sectioning of the aortic sinus and ascending aorta combined with histochemical and immunohistochemical analysis.
A subscription to JoVE is required to view this content. Sign in or start your free trial.
Method Article
We describe procedures to quantify and characterize atherosclerotic lesions in mouse models using precision sectioning of the aortic sinus and ascending aorta combined with histochemical and immunohistochemical analysis.
Atherosclerosis is a disease of the large arteries and a major underlying cause of myocardial infarction and stroke. Several different mouse models have been developed to facilitate the study of the molecular and cellular pathophysiology of this disease. In this manuscript we describe specific techniques for the quantification and characterization of atherosclerotic lesions in the murine aortic sinus and ascending aorta. The advantage of this procedure is that it provides an accurate measurement of the cross-sectional area and total volume of the lesion, which can be used to compare atherosclerotic progression across different treatment groups. This is possible through the use of the valve leaflets as an anatomical landmark, together with careful adjustment of the sectioning angle. We also describe basic staining methods that can be used to begin to characterize atherosclerotic progression. These can be further modified to investigate antigens of specific interest to the researcher. The described techniques are generally applicable to a wide variety of existing and newly created dietary and genetically-induced models of atherogenesis.
In the last two decades the development and use of atherosclerosis-prone mouse models through dietary and/or genetic manipulation have significantly increased our understanding of the molecular and cellular mechanisms involved in atherosclerotic lesion development1-3. A great deal of our knowledge and understanding of atherogenesis comes from studies carried out in apolipoprotein (Apo)-E deficient4 mice, in which atherosclerotic lesions develop spontaneously and low density lipoprotein receptor (LDLR)-deficient5 mice, in which ....
Access restricted. Please log in or start a trial to view this content.
The McMaster University Animal Research Ethics Board has preapproved all procedures described herein.
1. Harvesting Heart and Aorta
Access restricted. Please log in or start a trial to view this content.
Five week old LDLR-/- mice were fed a standard diet or a high fat diet for ten weeks. Mice were sacrificed and perfused with formalin as described above. Cross sections of the aortic sinus were prepared and stained with hematoxylin and eosin to determine lesion area and volume (Figure 4). When mice are fed a standard chow diet, atherosclerotic development is very limited and may not be detectable at 15 weeks of age. High fat diet significantly accelerates atherogenesis in this model and induces the form.......
Access restricted. Please log in or start a trial to view this content.
Atherosclerosis is a complex chronic disease of the large muscle arteries that is a major underlying cause of myocardial infarction and stroke. Disease progression involves the interplay of many different cell types within the artery wall, with circulating blood cells, lipoprotein particles and other blood-borne factors that we are just beginning to understand. Much of our current knowledge regarding the development and progression of atherosclerosis has come from studies carried out in specially designed atherosclerosis.......
Access restricted. Please log in or start a trial to view this content.
The authors declare that they have no competing financial interests.
This research was funded by an operating grant from the Canadian Institutes of Health Sciences and the Canadian Diabetes Association. DEV is supported by a scholarship from the Comisión Nacional de Investigación Científica y Tecnológica (CONICYT, Chile).
....Access restricted. Please log in or start a trial to view this content.
| Name | Company | Catalog Number | Comments |
|---|---|---|---|
| LDLR-deficient mice (D2.129S7(B6)-Ldlrtm1Her/J) | The Jackson Laboratory | stock #002207 | |
| Formalin | Sigma-Aldrich | HT5011 | |
| Histology Molds | Ted Pella Inc | 27195 | |
| Paraffin | Paramat | 19286-10 | |
| Coated slides | Fisher | 12-550-15 | |
| Solvent containers | Tissue Tek II | 4457 | |
| Microtome | Leica | RM22S5 | |
| Water bath | VWR | 80086-982 | |
| Microscope | Olympus | BX41TF | |
| Camera | Olympus | DP72 | |
| ImageJ | NIH | www.rsbweb.nih.gov/ij/ | |
| Processor | Sakura Finetek | VIP6-A1 | |
| Processing cassettes | VWR | 18000-134 | |
| Preassure Cooker | Nordic Ware | ||
| Coverslip | Fisher | 12-545-M | |
| PBS | Sigma-Aldrich | P3813 | |
| Microtome blade | Thermo Scientific | 30-518-35 | |
| Antifade mounting medium | Sigma-Aldrich | F-4680 | |
| Xylene mounting medium | Sigma-Aldrich | 44581 | |
| Aquous mounting medium | Sigma-Aldrich | I1161 | |
| Mac-3 anbody | BD Pharmingen | 553322 | |
| DAPI | Sigma-Aldrich | D9542 | |
| F4/80 antibody | Abcam | Ab6640 | |
| Alpha actin antibody | Santa Cruz Biotechnology | SC-32251 | |
| Mayer’s Hematoxylin | Sigma-Aldrich | E4382 | |
| Eosin Y | Sigma-Aldrich | MHS16 | |
| DAB (3,3'-Diaminobenzidine) | Dako | K3468 |
Access restricted. Please log in or start a trial to view this content.